A space for sharing and discussing news related to global current events, technology, and society.
64608 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
A space for sharing and discussing news related to global current events, technology, and society.
64608 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
Relevant
Hot
New
Spam
Relevant
Hot
New
Spam
0
3.1K
0
3.1K
The New York Times: F.D.A. Says Next Covid Boosters Should Target Omicron Subvariants. >"The decision was an acknowledgment that the current shots may no longer be _...Read More_
The New York Times: F.D.A. Says Next Covid Boosters Should Target Omicron Subvariants. >"The decision was an acknowledgment that the current shots may no longer be _...Read More_
0
262
0
262
The New York Times: Young U.S. Children Will Start Getting Vaccines, Though Hurdles Remain. >"Although opening up shots for children under 5 is a milestone, this _...Read More_
The New York Times: Young U.S. Children Will Start Getting Vaccines, Though Hurdles Remain. >"Although opening up shots for children under 5 is a milestone, this _...Read More_
0
217
0
217
The New York Times: F.D.A. Panel Recommends Pfizer and Moderna Vaccines for Youngest Children. >"States have already ordered millions of doses; if the agency _...Read More_
The New York Times: F.D.A. Panel Recommends Pfizer and Moderna Vaccines for Youngest Children. >"States have already ordered millions of doses; if the agency _...Read More_
50
30.6K
50
30.6K
"Scientific advisers to the Centers for Disease Control and Prevention voted unanimously on Saturday to recommend Covid vaccines for children under age 5, the last group of Americans to qualify for the shots, except for infants younger than _...Read More_
"Scientific advisers to the Centers for Disease Control and Prevention voted unanimously on Saturday to recommend Covid vaccines for children under age 5, the last group of Americans to qualify for the shots, except for infants younger than _...Read More_
0
321
0
321
CNBC: Stocks making the biggest moves midday: Moderna, Robinhood, Snowflake and more. >"Check out the stocks making _...Read More_
CNBC: Stocks making the biggest moves midday: Moderna, Robinhood, Snowflake and more. >"Check out the stocks making _...Read More_
52
34.9K
52
34.9K
"A greenlight from the FDA, followed by an endorsement by the Centers for Disease Control and Prevention, would give parents another choice of shots for school-age children and adolescents. The Pfizer-BioNTech vaccine already is available _...Read More_
"A greenlight from the FDA, followed by an endorsement by the Centers for Disease Control and Prevention, would give parents another choice of shots for school-age children and adolescents. The Pfizer-BioNTech vaccine already is available _...Read More_
50
33.2K
50
33.2K
>"If the vaccine receives the agency’s authorization, it may have little immediate impact, since the age group has had access to Pfizer-BioNTech shots for _...Read More_
>"If the vaccine receives the agency’s authorization, it may have little immediate impact, since the age group has had access to Pfizer-BioNTech shots for _...Read More_
0
807
0
807
The New York Times: Moderna’s Covid Vaccine Is Effective in Children Under 6, F.D.A. Says. >"Outside experts will meet next week to decide whether to _...Read More_
The New York Times: Moderna’s Covid Vaccine Is Effective in Children Under 6, F.D.A. Says. >"Outside experts will meet next week to decide whether to _...Read More_
49
30.4K
49
30.4K
"A significantly stronger immune response against Omicron is seen, but it remains unclear how an updated vaccine will fare against future versions of the virus."
"A significantly stronger immune response against Omicron is seen, but it remains unclear how an updated vaccine will fare against future versions of the virus."
0
301
0
301
The New York Times: Revised Moderna Vaccine Works Better Against Omicron, Trial Suggests. >"The findings indicate that the updated vaccine produced a _...Read More_
The New York Times: Revised Moderna Vaccine Works Better Against Omicron, Trial Suggests. >"The findings indicate that the updated vaccine produced a _...Read More_
0
175
0
175
The New York Times: F.D.A. Sets Aside June for Potential Decisions on Vaccines for Children Under 5. >"Both Moderna and Pfizer-BioNTech have asked the agency _...Read More_
The New York Times: F.D.A. Sets Aside June for Potential Decisions on Vaccines for Children Under 5. >"Both Moderna and Pfizer-BioNTech have asked the agency _...Read More_
54
31.8K
54
31.8K
>"The company has also requested authorization of its Covid vaccine for 6- to 11-year-olds and 12- to 17-year-olds."
>"The company has also requested authorization of its Covid vaccine for 6- to 11-year-olds and 12- to 17-year-olds."
0
57.3
0
57.3
The New York Times: Moderna Says Trial Suggests Redesigned Vaccines Protect Against Variants. >"Researchers combined Moderna’s existing vaccine with one _...Read More_
The New York Times: Moderna Says Trial Suggests Redesigned Vaccines Protect Against Variants. >"Researchers combined Moderna’s existing vaccine with one _...Read More_
0
81.8
0
81.8
The New York Times: F.D.A. Panel Weighs Challenges of Revamping Covid Vaccines for Fall. >"A meeting of the committee underscored how many _...Read More_
The New York Times: F.D.A. Panel Weighs Challenges of Revamping Covid Vaccines for Fall. >"A meeting of the committee underscored how many _...Read More_
54
15.5K
54
15.5K
"People in the age group can get the additional shot at least four months after their first booster. Those 12 and older with certain immune deficiencies _...Read More_
"People in the age group can get the additional shot at least four months after their first booster. Those 12 and older with certain immune deficiencies _...Read More_